Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 PCDHA9 SYT9 ADGRV1 STAB1 ESYT2 FAT1 DST SYT13 HSPG2 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCLO PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 MACF1 PCDHGA8 CDH15	5.38e-06	749	259	26	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 PCDHA9 FAT1 NECTIN4 FAT4 SDK2 DSCAM DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.39e-13	187	257	20	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 PCDHA9 FAT1 NECTIN4 FAT4 SDK2 DSCAM DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 GRID2 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	4.44e-10	313	257	21	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 PCDHA9 ADGRV1 ITGAV FAT1 NECTIN4 TLN2 FAT4 SDK2 DSCAM DSG2 PCDHGA11 KIF26B PCDHGA6 FAT3 CAMSAP3 ITGA10 LAMA3 PCDHA13 PCDHA11 PCDHA8 GPAM PCDHA6 GRID2 PCDHA4 PCDHA2 PCDHA1 SIGLEC1 PCDHGA8 CDH15	3.28e-05	1077	257	30	GO:0098609
MousePheno	increased spleen germinal center number	C4A C4B C5AR1 BANK1 PLD4 RGS13 BECN1	4.36e-08	26	192	7	MP:0008481
MousePheno	abnormal macrophage cell number	AKR1A1 KMT2E LYST C3 C4A ADGRF5 C4B C5AR1 PLD4 HSPG2 LAMA3 IL18BP RIOX2 DCLRE1C	3.02e-05	278	192	14	MP:0020202
Domain	Cadherin_CS	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	1.17e-13	109	254	17	IPR020894
Domain	CADHERIN_1	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.15e-13	113	254	17	PS00232
Domain	Cadherin	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.15e-13	113	254	17	PF00028
Domain	-	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.50e-13	114	254	17	2.60.40.60
Domain	CADHERIN_2	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.50e-13	114	254	17	PS50268
Domain	CA	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	2.90e-13	115	254	17	SM00112
Domain	Cadherin-like	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	3.36e-13	116	254	17	IPR015919
Domain	Cadherin	DCHS2 PCDHA9 FAT1 FAT4 DSG2 PCDHGA11 PCDHGA6 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8 CDH15	4.48e-13	118	254	17	IPR002126
Domain	Cadherin_tail	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.48e-12	37	254	11	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.48e-12	37	254	11	IPR031904
Domain	Cadherin_2	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.11e-09	65	254	11	PF08266
Domain	Cadherin_N	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.11e-09	65	254	11	IPR013164
Domain	DEP_dom	DVL1P1 RAPGEF3 DVL1 PIKFYVE FMN2 DEPDC5	4.96e-07	23	254	6	IPR000591
Domain	DEP	DVL1P1 RAPGEF3 DVL1 PIKFYVE DEPDC5	9.75e-06	22	254	5	PF00610
Domain	DEP	DVL1P1 RAPGEF3 DVL1 PIKFYVE DEPDC5	9.75e-06	22	254	5	PS50186
Domain	DEP	DVL1P1 RAPGEF3 DVL1 PIKFYVE DEPDC5	9.75e-06	22	254	5	SM00049
Domain	Anaphylatoxn_comp_syst_dom	C3 C4A C4B	2.44e-05	5	254	3	IPR001840
Domain	Anaphylatoxin_comp_syst	C3 C4A C4B	2.44e-05	5	254	3	IPR018081
Domain	LamG	FAT1 HSPG2 FAT4 FAT3 LAMA3 COL18A1	2.73e-05	44	254	6	SM00282
Domain	ARM-type_fold	GPRASP1 TRRAP LYST PI4KA PUM3 GCN1 UNC79 DOCK1 ZYG11A RANBP6 APOB HEATR5A RALGAPA2 PPP4R3B DAAM2	6.67e-05	339	254	15	IPR016024
Domain	ANATO	C3 C4A C4B	8.36e-05	7	254	3	SM00104
Domain	ANAPHYLATOXIN_2	C3 C4A C4B	8.36e-05	7	254	3	PS01178
Domain	ANAPHYLATOXIN_1	C3 C4A C4B	8.36e-05	7	254	3	PS01177
Domain	Anaphylatoxin/fibulin	C3 C4A C4B	8.36e-05	7	254	3	IPR000020
Domain	ANATO	C3 C4A C4B	8.36e-05	7	254	3	PF01821
Domain	MacrogloblnA2_thiol-ester-bond	C3 C4A C4B	1.32e-04	8	254	3	IPR019565
Domain	Thiol-ester_cl	C3 C4A C4B	1.32e-04	8	254	3	PF10569
Domain	MacrogloblnA2_CS	C3 C4A C4B	1.32e-04	8	254	3	IPR019742
Domain	Laminin_G	FAT1 HSPG2 FAT4 FAT3 LAMA3 COL18A1	1.34e-04	58	254	6	IPR001791
Domain	LAM_G_DOMAIN	FAT1 HSPG2 FAT4 FAT3 LAMA3	1.56e-04	38	254	5	PS50025
Domain	DVL-1	DVL1P1 DVL1	1.84e-04	2	254	2	IPR008340
Domain	Laminin_G_2	FAT1 HSPG2 FAT4 FAT3 LAMA3	1.99e-04	40	254	5	PF02210
Domain	ConA-like_dom	ADGRV1 TRIM14 ADGRG4 FAT1 PTPRK HSPG2 TRIM15 FAT4 FAT3 LAMA3 COL18A1	2.13e-04	219	254	11	IPR013320
Domain	Spectrin	DST SYNE2 SYNE1 MACF1	2.41e-04	23	254	4	PF00435
Domain	ACTININ_2	DST SYNE2 SYNE1 MACF1	2.41e-04	23	254	4	PS00020
Domain	ACTININ_1	DST SYNE2 SYNE1 MACF1	2.41e-04	23	254	4	PS00019
Domain	Actinin_actin-bd_CS	DST SYNE2 SYNE1 MACF1	2.41e-04	23	254	4	IPR001589
Domain	A2M	C3 C4A C4B	2.78e-04	10	254	3	PF00207
Domain	A2M_N_2	C3 C4A C4B	2.78e-04	10	254	3	IPR011625
Domain	A2M_comp	C3 C4A C4B	2.78e-04	10	254	3	IPR011626
Domain	A2M_recep	C3 C4A C4B	2.78e-04	10	254	3	PF07677
Domain	A2M_comp	C3 C4A C4B	2.78e-04	10	254	3	PF07678
Domain	A2M_N_2	C3 C4A C4B	2.78e-04	10	254	3	PF07703
Domain	A2M_N	C3 C4A C4B	2.78e-04	10	254	3	PF01835
Domain	A2M_N	C3 C4A C4B	2.78e-04	10	254	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	C3 C4A C4B	2.78e-04	10	254	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C3 C4A C4B	2.78e-04	10	254	3	PS00477
Domain	Macroglobln_a2	C3 C4A C4B	2.78e-04	10	254	3	IPR001599
Domain	-	ADGRV1 ADGRG4 FAT1 HSPG2 FAT4 FAT3 LAMA3	3.16e-04	95	254	7	2.60.120.200
Domain	Spectrin_repeat	DST SYNE2 SYNE1 MACF1	6.07e-04	29	254	4	IPR002017
Domain	EGF_LAM_2	STAB1 HSPG2 LAMA3 LAMB2	6.93e-04	30	254	4	PS50027
Domain	EGF_LAM_1	STAB1 HSPG2 LAMA3 LAMB2	6.93e-04	30	254	4	PS01248
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH6 DYNC1H1	8.10e-04	14	254	3	IPR011704
Domain	AAA_5	MDN1 DNAH6 DYNC1H1	8.10e-04	14	254	3	PF07728
Domain	SEA	ADGRF5 HSPG2 MUC16	8.10e-04	14	254	3	SM00200
Domain	SPEC	DST SYNE2 SYNE1 MACF1	8.90e-04	32	254	4	SM00150
Domain	Spectrin/alpha-actinin	DST SYNE2 SYNE1 MACF1	8.90e-04	32	254	4	IPR018159
Domain	Lactamase_B	ELAC2 DCLRE1C ETHE1	1.00e-03	15	254	3	SM00849
Domain	KASH	SYNE2 SYNE1	1.09e-03	4	254	2	PS51049
Domain	Dishevelled	DVL1P1 DVL1	1.09e-03	4	254	2	PF02377
Domain	Lactamase_B_2	ELAC2 DCLRE1C	1.09e-03	4	254	2	PF12706
Domain	KASH	SYNE2 SYNE1	1.09e-03	4	254	2	PF10541
Domain	Dishevelled_fam	DVL1P1 DVL1	1.09e-03	4	254	2	IPR008339
Domain	-	C3 C4A	1.09e-03	4	254	2	1.20.91.20
Domain	KASH	SYNE2 SYNE1	1.09e-03	4	254	2	IPR012315
Domain	KASH	SYNE2 SYNE1	1.09e-03	4	254	2	SM01249
Domain	Dishevelled_protein_dom	DVL1P1 DVL1	1.09e-03	4	254	2	IPR003351
Domain	EGF_Lam	STAB1 HSPG2 LAMA3 LAMB2	1.26e-03	35	254	4	SM00180
Domain	Laminin_EGF	STAB1 HSPG2 LAMA3 LAMB2	1.26e-03	35	254	4	PF00053
Domain	C345C	C3 C4A C4B	1.47e-03	17	254	3	SM00643
Domain	Laminin_EGF	STAB1 HSPG2 LAMA3 LAMB2	1.71e-03	38	254	4	IPR002049
Domain	Terpenoid_cyclase/PrenylTrfase	C3 C4A C4B	1.74e-03	18	254	3	IPR008930
Domain	TMEM132D_N	TMEM132B TMEM132C	1.79e-03	5	254	2	PF15705
Domain	TMEM132D_C	TMEM132B TMEM132C	1.79e-03	5	254	2	PF15706
Domain	Vmron_rcpt_1	VN1R3 VN1R4	1.79e-03	5	254	2	IPR004072
Domain	TMEM132	TMEM132B TMEM132C	1.79e-03	5	254	2	IPR026307
Domain	TMEM132_M	TMEM132B TMEM132C	1.79e-03	5	254	2	IPR031437
Domain	TMEM132_C	TMEM132B TMEM132C	1.79e-03	5	254	2	IPR031436
Domain	TMEM132_N	TMEM132B TMEM132C	1.79e-03	5	254	2	IPR031435
Domain	BPI/LBP	PLTP BPIFB2	1.79e-03	5	254	2	IPR030675
Domain	COUP_TF	HNF4A NR2F2	1.79e-03	5	254	2	IPR003068
Domain	V1R	VN1R3 VN1R4	1.79e-03	5	254	2	PF03402
Domain	TMEM132	TMEM132B TMEM132C	1.79e-03	5	254	2	PF16070
Domain	NTR	C3 C4A C4B	2.05e-03	19	254	3	PF01759
Domain	Netrin_module_non-TIMP	C3 C4A C4B	2.05e-03	19	254	3	IPR018933
Domain	-	ELAC2 DCLRE1C ETHE1	2.39e-03	20	254	3	3.60.15.10
Domain	Metallo-B-lactamas	ELAC2 DCLRE1C ETHE1	2.39e-03	20	254	3	IPR001279
Domain	Cadherin_C	PCDHA9 PCDHGA11 PCDHGA6 PCDHGA8	2.49e-03	42	254	4	IPR032455
Domain	Cadherin_C_2	PCDHA9 PCDHGA11 PCDHGA6 PCDHGA8	2.49e-03	42	254	4	PF16492
Domain	CH	DST SYNE2 SYNE1 CAMSAP3 MACF1	2.64e-03	70	254	5	PF00307
Domain	GAR	DST MACF1	2.67e-03	6	254	2	PS51460
Domain	Myb-like_dom	DMTF1 EP400	2.67e-03	6	254	2	IPR017877
Domain	GAS_dom	DST MACF1	2.67e-03	6	254	2	IPR003108
Domain	-	DST MACF1	2.67e-03	6	254	2	3.90.1290.10
Domain	GAS2	DST MACF1	2.67e-03	6	254	2	PF02187
Domain	-	DST MACF1	2.67e-03	6	254	2	3.30.920.20
Domain	GAS2	DST MACF1	2.67e-03	6	254	2	SM00243
Domain	-	GALK2 LONP2 TOP2A	2.76e-03	21	254	3	3.30.230.10
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	6.23e-15	28	264	10	15347688
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	6.09e-14	15	264	8	15640798
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.27e-13	17	264	8	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	4.06e-13	18	264	8	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	4.06e-13	18	264	8	10662547
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	4.09e-12	68	264	11	11230163
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	6.56e-12	24	264	8	24698270
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	7.86e-12	72	264	11	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.07e-11	74	264	11	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.68e-11	77	264	11	10835267
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	1.69e-11	57	264	10	32633719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ACACA MYO7A CC2D1A PIGG TRRAP BIRC6 LYST ELAC2 ADCY7 FAT1 DST MDN1 KCNG1 PI4KA TLN2 GCN1 TTC38 DYNC1H1 AGAP3 HSPG2 EP400 DVL1 LAMB2 SMG5 RALGAPA2 NR2F2 KANSL3 PIKFYVE FANCI ZFYVE26 DEPDC5 TNFAIP2 SLC45A1	2.42e-11	1105	264	33	35748872
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	2.58e-11	80	264	11	10716726
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4	8.09e-11	11	264	6	9655502
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4	1.61e-10	12	264	6	10612399
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA9 CCNO RBM27 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	2.88e-10	75	264	10	15372022
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	5.62e-10	58	264	9	30377227
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ADGRV1 BIRC6 STAB1 ESYT2 DST SYNE2 TLN2 CAMTA1 GCN1 SYNE1 ALS2 CHD7 SMG5 MACF1	2.33e-09	225	264	14	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UBAP2 ADGRV1 STAB1 DST INTS2 RBM27 MED23 SYT13 SDK2 PDCD6IP SASH1 EP400 PHRF1 ZNF507 KIAA1549 SMG5 KANSL3 PPP4R3B TET1 DEPDC5	5.32e-09	529	264	20	14621295
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	UBAP2 ACACA MYO9A CC2D1A LYST ESYT2 DST MDN1 PI4KA SYNE2 KIF11 AGAP3 PDCD6IP SASH1 DSG2 KIF26B NCKIPSD CAMSAP3 ALS2 RESF1 TET1 FMN2 MACF1 BECN1 OTOG	1.28e-08	861	264	25	36931259
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA9 PCDHGA11 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 SLC26A7	2.76e-08	119	264	10	28625976
Pubmed	Modulation of the antitumor immune response by complement.	C3 C4A C4B C5AR1	4.81e-08	6	264	4	18820683
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCAF1 KIAA0586 MRPS27 TRIM14 BIRC6 ATAD3C KCNS2 PUM3 ADGRF5 NUP160 CEP290 ARHGEF18 GPAM TRAPPC8 RALGAPA2 PIKFYVE ZNF526 MACF1	5.35e-08	493	264	18	15368895
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ACACA MYO7A LRRC70 BIRC6 TMEM132B DST MDN1 KCNG1 PI4KA KCNS2 BANK1 DYNC1H1 FAT4 MXRA5 KIF26B PCLO CEP290 CAMSAP3 GPAM RIOX2 FMN2 MTMR9	6.02e-08	736	264	22	29676528
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PCDHA9 MDN1 TLN2 DYNC1H1 ADAMTS3 CEP290 DAAM2 ZFYVE26 PCDHGA8	1.07e-07	104	264	9	9205841
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT1 FAT4 FAT3	1.12e-07	7	264	4	16059920
Pubmed	Complement C3a signaling facilitates skeletal muscle regeneration by regulating monocyte function and trafficking.	C3 C4A C4B C5AR1	1.12e-07	7	264	4	29233958
Pubmed	Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.	C3 C4A C4B C5AR1	2.22e-07	8	264	4	28301559
Pubmed	Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17.	C3 C4A C4B	4.32e-07	3	264	3	681746
Pubmed	Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.	C3 C4A C4B	4.32e-07	3	264	3	8524789
Pubmed	Immune complex glomerulonephritis in C4- and C3-deficient mice.	C3 C4A C4B	4.32e-07	3	264	3	9461092
Pubmed	Regulation of the B cell response to T-dependent antigens by classical pathway complement.	C3 C4A C4B	4.32e-07	3	264	3	8752901
Pubmed	Complement genes contribute sex-biased vulnerability in diverse disorders.	C3 C4A C4B	4.32e-07	3	264	3	32499649
Pubmed	Role of complement in a murine model of peanut-induced anaphylaxis.	C3 C4A C4B	4.32e-07	3	264	3	23182714
Pubmed	Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma.	C3 C4A C4B	4.32e-07	3	264	3	35017157
Pubmed	Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.	C3 C4A C4B	4.32e-07	3	264	3	14500686
Pubmed	In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.	C3 C4A C4B	4.32e-07	3	264	3	21723612
Pubmed	Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria.	C3 C4A C4B	4.32e-07	3	264	3	9829481
Pubmed	Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.	C3 C4A C4B	4.32e-07	3	264	3	16893076
Pubmed	Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes.	C3 C4A C4B	4.32e-07	3	264	3	37234916
Pubmed	Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli.	C3 C4A C4B	4.32e-07	3	264	3	11433344
Pubmed	Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.	C3 C4A C4B	4.32e-07	3	264	3	9218619
Pubmed	Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.	C3 C4A C4B C5AR1	6.58e-07	10	264	4	30429287
Pubmed	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	DMTF1 FAT4 SYNE1 PCLO	1.03e-06	11	264	4	20351715
Pubmed	Impaired mast cell-dependent natural immunity in complement C3-deficient mice.	C3 C4A C4B	1.72e-06	4	264	3	9367154
Pubmed	Complement C4 is protective for lupus disease independent of C3.	C3 C4A C4B	1.72e-06	4	264	3	11801636
Pubmed	A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.	C3 C4A C4B	1.72e-06	4	264	3	10934224
Pubmed	The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).	C3 C4A C5AR1	1.72e-06	4	264	3	11773063
Pubmed	Intestinal reperfusion injury is mediated by IgM and complement.	C3 C4A C4B	1.72e-06	4	264	3	10066708
Pubmed	Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.	C3 C4A C4B	1.72e-06	4	264	3	15477230
Pubmed	Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first.	C3 C4A C4B	1.72e-06	4	264	3	8015436
Pubmed	The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.	C3 C4A C4B	1.72e-06	4	264	3	15102802
Pubmed	Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells.	C3 C4A C4B	1.72e-06	4	264	3	16304047
Pubmed	Efficient amyloid A clearance in the absence of immunoglobulins and complement factors.	C3 C4A C4B	1.72e-06	4	264	3	23454183
Pubmed	The human complement system: assembly of the classical pathway C3 convertase.	C3 C4A C4B	1.72e-06	4	264	3	6906228
Pubmed	Functional analysis of Ficolin-3 mediated complement activation.	C3 C4A C4B	1.72e-06	4	264	3	21085669
Pubmed	Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice.	C3 C4A C4B	1.72e-06	4	264	3	9409643
Pubmed	Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.	C3 C4A C4B	1.72e-06	4	264	3	30301856
Pubmed	Allelic distribution of complement components BF, C4A, C4B, and C3 in Psoriasis vulgaris.	C3 C4A C4B	1.72e-06	4	264	3	11803045
Pubmed	Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.	C3 C4A C4B	1.72e-06	4	264	3	19302245
Pubmed	Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.	C3 C4A C4B	1.72e-06	4	264	3	18452991
Pubmed	Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.	C3 C4A C4B C5AR1	2.20e-06	13	264	4	23427256
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	AZU1 CC2D1A AKR1A1 ITGAV NECTIN4 C3 C4A C4B TTC38 DYNC1H1 HSPG2 COL6A3 FAT4 PDCD6IP LAMA3 LAMB2 APOB IL18BP COL18A1 CUTA SERPINC1 BPIFB2 TNXA CDH15	2.61e-06	1070	264	24	23533145
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	RBM27 UNC79 SYT13 MUC20 PDCD6IP HEATR5A CHD7 KANSL3 PPP4R3B	2.81e-06	153	264	9	10718198
Pubmed	The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.	C4A C4B C5AR1	4.28e-06	5	264	3	21393236
Pubmed	The generation of thymus-independent germinal centers depends on CD40 but not on CD154, the T cell-derived CD40-ligand.	C3 C4A C4B	4.28e-06	5	264	3	16783845
Pubmed	Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction.	C3 C4A C4B	4.28e-06	5	264	3	18056835
Pubmed	Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis.	C3 C4A C4B	4.28e-06	5	264	3	21707943
Pubmed	Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.	C3 C4A C4B	4.28e-06	5	264	3	15192652
Pubmed	A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.	C3 C4A C4B	4.28e-06	5	264	3	9382884
Pubmed	Protective T cell-independent antiviral antibody responses are dependent on complement.	C3 C4A C4B	4.28e-06	5	264	3	10523614
Pubmed	Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.	C3 C4A C4B	4.28e-06	5	264	3	17947689
Pubmed	The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.	C3 C4A C4B	4.28e-06	5	264	3	22689574
Pubmed	Predominant role for C5b-9 in renal ischemia/reperfusion injury.	C3 C4A C4B	4.28e-06	5	264	3	10811844
Pubmed	Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.	C3 C4A C4B	4.28e-06	5	264	3	25039245
Pubmed	Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice.	C3 C4A C4B	4.28e-06	5	264	3	19710463
Pubmed	The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene.	C4A C4B TNXA	4.28e-06	5	264	3	1988494
Pubmed	Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.	C3 C4A C4B	4.28e-06	5	264	3	29743491
Pubmed	Formation of high affinity C5 convertase of the classical pathway of complement.	C3 C4A C4B	4.28e-06	5	264	3	12878586
Pubmed	Complement C4A Regulates Autoreactive B Cells in Murine Lupus.	C3 C4A C4B	4.28e-06	5	264	3	33147456
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACA BIRC6 DST GCN1 KIF11 CAMSAP3 ZNF507 DVL1 CHD7 RLF NOL4L RESF1 WDCP TET1	4.50e-06	418	264	14	34709266
Pubmed	A human MAP kinase interactome.	MYO9A PARD6B DST C4A GCN1 DOCK1 PDCD6IP KIF26B CCDC186 SYNE1 CEP290 LAMA3 LAMB2 PIAS1 MACF1	5.51e-06	486	264	15	20936779
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	KIAA0586 C8orf34 FAT1 MDN1 SYNE2 SEPTIN1 UNC79 MUC16 OTOG	6.65e-06	170	264	9	23314748
Pubmed	Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.	C3 C4A C4B DYNC1H1 APOB COL18A1 SERPINC1	6.78e-06	92	264	7	37343697
Pubmed	Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro.	C3 C4A C4B	8.50e-06	6	264	3	15597324
Pubmed	Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.	FANCD2 PIAS1 FANCI	8.50e-06	6	264	3	25557546
Pubmed	CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.	C3 C4A C4B	8.50e-06	6	264	3	19710450
Pubmed	Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice.	C3 C4A C4B	8.50e-06	6	264	3	17363917
Pubmed	Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival and proliferation.	FANCD2 ATAD3C FANCI	8.50e-06	6	264	3	31472450
Pubmed	Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication.	C4A C4B TNXA	8.50e-06	6	264	3	8132574
Pubmed	A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.	C3 C4A C4B	8.50e-06	6	264	3	16615889
Pubmed	A physical interaction network of dengue virus and human proteins.	DST PDCD6IP APOB PIAS1	9.13e-06	18	264	4	21911577
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	HSPG2 COL6A3 ADAMTS3 LAMB2 APOB COL18A1	9.37e-06	64	264	6	22261194
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BIRC6 ESYT2 INTS2 MED23 SYNE1 RALGAPA2 MACF1	1.43e-05	103	264	7	10574462
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	TRRAP DST SYNE2 DNAH6 NUP160 KIF11 COL6A3 MXRA5 SYNE1	1.43e-05	187	264	9	26460568
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT1 FAT4 FAT3	1.48e-05	7	264	3	22510986
Pubmed	Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1.	C3 C4A C4B	1.48e-05	7	264	3	20139276
Pubmed	A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3.	C3 C4A C4B	1.48e-05	7	264	3	22037602
Pubmed	Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.	C4A C4B C5AR1	1.48e-05	7	264	3	14660741
Pubmed	Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.	C3 C4A C4B	1.48e-05	7	264	3	12055255
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2	6.57e-09	22	253	7	int:PCDHA10
Interaction	FLT3 interactions	PCDHA9 TRRAP MDN1 PI4KA PUM3 GCN1 DYNC1H1 PCDHGA11 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 APOB PCDHA1 SLC26A7 FANCI	1.22e-07	318	253	18	int:FLT3
Interaction	PCDHA9 interactions	PCDHA9 PCDHGA11 LONP2 PCDHGA6 PCDHA11 PCDHA4	2.54e-06	32	253	6	int:PCDHA9
Interaction	CEACAM8 interactions	ADGRV1 ITGAV FAT1 PTPRK MANEAL PLTP FAT4 SDK2 LAMA3 KIAA1549	2.61e-06	119	253	10	int:CEACAM8
Interaction	PCDHA1 interactions	PCDHA11 PCDHA8 PCDHA4 PCDHA1	2.91e-06	9	253	4	int:PCDHA1
Interaction	PCDHA11 interactions	PCDHA9 LONP2 PCDHA11 PCDHA4 PCDHA1	3.02e-06	19	253	5	int:PCDHA11
Interaction	PCDHA3 interactions	PCDHA9 LONP2 PCDHA11 PCDHA8 PCDHA6 PCDHA1	3.70e-06	34	253	6	int:PCDHA3
Interaction	SLAMF1 interactions	ADGRV1 FAT1 INTS2 LAMA3 LAMB2 NR2F2 RGS13 FANCI TNFAIP2 BECN1	4.08e-06	125	253	10	int:SLAMF1
Interaction	PCDHA8 interactions	LONP2 PCDHA13 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	5.49e-06	55	253	7	int:PCDHA8
Interaction	PCDHA7 interactions	PCDHA9 PCDHA8 PCDHA4 PCDHA2	2.20e-05	14	253	4	int:PCDHA7
Interaction	CD160 interactions	ADGRV1 ITGAV FAT1 PTPRK FAT4 FAT3	2.91e-05	48	253	6	int:CD160
Interaction	TOP3B interactions	UBAP2 ACACA MYO7A CC2D1A PIGG TRRAP BIRC6 LYST ELAC2 ADCY7 FAT1 DST MDN1 KCNG1 PI4KA TLN2 GCN1 TTC38 DYNC1H1 AGAP3 HSPG2 PDCD6IP EP400 DVL1 LAMB2 APOB SMG5 RALGAPA2 NR2F2 KANSL3 PIKFYVE FANCI ZFYVE26 DEPDC5 TNFAIP2 SLC45A1 MRPL11	3.93e-05	1470	253	37	int:TOP3B
Interaction	TAFA5 interactions	ADGRV1 PLTP FAT4 SDK2	6.46e-05	18	253	4	int:TAFA5
Interaction	RYK interactions	DVL1P1 DST PTPRK DYNC1H1 FAT4 SDK2 DSG2 PCDHGA11 PCDHGA6 FAT3 DVL1	8.00e-05	212	253	11	int:RYK
Interaction	PCDHGA10 interactions	PCDHA9 PCDHA11 PCDHA8 PCDHA4	8.10e-05	19	253	4	int:PCDHGA10
Interaction	DCANP1 interactions	FAT1 FAT4 PCDHGA11 FAT3	8.10e-05	19	253	4	int:DCANP1
Cytoband	5q31	PCDHA9 SLC4A9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	3.71e-12	115	264	12	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 SLC4A9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	1.95e-07	298	264	12	chr5q31
GeneFamily	Clustered protocadherins	PCDHA9 PCDHGA11 PCDHGA6 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 PCDHGA8	3.30e-11	64	180	11	20
GeneFamily	Cadherin related	DCHS2 FAT1 FAT4 FAT3	2.04e-05	17	180	4	24
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C3 C4A C4B	7.80e-05	9	180	3	1234
GeneFamily	Immunoglobulin like domain containing	HEPACAM PTPRK ADGRF5 HSPG2 SDK2 MXRA5 DSCAM IL18BP CD96	1.39e-04	193	180	9	594
GeneFamily	Complement system\|Sushi domain containing	C3 C4A C4B C5AR1	4.36e-04	36	180	4	492
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE2 SYNE1	5.84e-04	4	180	2	1252
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	PUM3 TYMP RESF1 LY75	1.65e-03	51	180	4	870
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	2.65e-03	8	180	2	939
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	PDK4 STAB1 DST C5AR1 PLTP SASH1 DSCAM TYMP DAAM2 SIGLEC1 TNFAIP2	1.09e-08	180	263	11	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FAT1 TLN2 UNC79 FAT4 KIF26B FAT3 PCLO APOB GRIK3 OTOG	1.37e-08	184	263	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FAT1 TLN2 UNC79 FAT4 KIF26B FAT3 PCLO APOB GRIK3 OTOG	1.37e-08	184	263	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 FAT1 TLN2 UNC79 FAT4 KIF26B FAT3 PCLO APOB GRIK3 OTOG	1.37e-08	184	263	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 BIRC6 DST SYNE2 TOX3 ADGRF5 FAT4 CHD7 RALGAPA2 RESF1 MACF1	3.24e-08	200	263	11	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A SYT9 PARD6B HSPG2 DPP6 LAMA3 HEATR5A GRIK3 LRRC1 DAAM2	1.07e-07	177	263	10	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA MYO9A ADGRV1 C8orf34 PARD6B SLC9C1 PTPRK ADGRF5 SYNE1 LAMA3	2.64e-07	195	263	10	9406866f99555198a9be311fbd65751b70f35446
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMGCS2 LIN7A SLC9C1 SLCO1C1 TRPV1 PYROXD2 ITGA10 GRIK3	4.23e-07	115	263	8	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMGCS2 LIN7A SLC9C1 SLCO1C1 TRPV1 PYROXD2 ITGA10 GRIK3	4.23e-07	115	263	8	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMGCS2 LIN7A SLC9C1 SLCO1C1 TRPV1 PYROXD2 ITGA10 GRIK3	4.23e-07	115	263	8	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE2 UGT2A1 ATG9B EID2 IL18BP NOL4L RESF1 GZMK PCDHGA8	6.62e-07	166	263	9	9e916fc1858573358e1eb5e3789b2c9f8ef74476
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DST ACSM5 TLN2 COL6A3 FAT4 ITGA10 PODN MACF1 DAAM2	1.03e-06	175	263	9	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDX59 CC2D1A TMEM132B MDN1 MUC20 FAT3 LAMB2 TNFAIP2 MTMR9	1.03e-06	175	263	9	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 STAP1 LIN7A ADGRF5 SLC4A9 ADAMTS3 C4orf54 SLC26A7 GYG1	1.08e-06	176	263	9	cb21342dd135cc80a50aafe7bf8bf31265db68dd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 STAP1 LIN7A TOX3 ADGRF5 SLC4A9 DSCAM DSG2 SLC26A7	1.13e-06	177	263	9	8e4005fad50e6f919da175f3b9ae58849dbd60b1
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPRASP1 RBM27 COL6A3 PCDHGA6 FAT3 PCDHA4 TET1 DAAM2 CATSPERB	1.18e-06	178	263	9	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPRASP1 RBM27 COL6A3 PCDHGA6 FAT3 PCDHA4 TET1 DAAM2 CATSPERB	1.18e-06	178	263	9	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GPRASP1 RBM27 COL6A3 PCDHGA6 FAT3 PCDHA4 TET1 DAAM2 CATSPERB	1.18e-06	178	263	9	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCHS2 MYO9A FAT1 RAPGEF3 SYNE2 DPP6 ADAMTS3 KIF26B FMN2	1.18e-06	178	263	9	544379f5a6145429762258d426b876bb36c112f5
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|390C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 CCNO PLEKHS1 TOX3 NECTIN4 MUC16 GRIK3 BPIFB2 TNFAIP2	1.18e-06	178	263	9	fce60ce6b662f1bdaa3b4da43800c6c22fe89533
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 CCNO PLEKHS1 TOX3 NECTIN4 MUC16 GRIK3 BPIFB2 TNFAIP2	1.18e-06	178	263	9	b19c906e067b07eadfd68934d9330b447e24c708
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCX LIN7A PARD6B NECTIN4 OLFM1 KIF26B PCLO CHD7 CDH15	1.78e-06	187	263	9	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	CCNO STAP1 SLC9C1 FAT1 ADGRF5 C4B MUC20 HSPG2 MUC16	1.86e-06	188	263	9	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYT9 HMGCS2 STAP1 LIN7A ESYT2 SLC9C1 TOX3 SLC4A9 SLC26A7	1.95e-06	189	263	9	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMEM132B LIN7A TMEM132C FAT1 COL6A3 SYNE1 GRID2 NR2F2 DAAM2	2.12e-06	191	263	9	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG4 STAT4 TMEM132C SYNE2 TTC38 SYNE1 GZMK MACF1 CD96	2.21e-06	192	263	9	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG4 STAT4 TMEM132C SYNE2 TTC38 SYNE1 GZMK MACF1 CD96	2.21e-06	192	263	9	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	RGSL1 PDK4 C19orf84 C3 C5AR1 PLD4 C12orf71 DAAM2 MRNIP	2.41e-06	194	263	9	4f28841c7f37884fc34c6689cd6976c6559d23f1
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPATA33 KCNS2 UNC79 SLC4A9 SYT13 FAT3 MUC16 FMN2 PCSK4	2.41e-06	194	263	9	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	RGSL1 PDK4 C19orf84 C3 C5AR1 PLD4 C12orf71 DAAM2 MRNIP	2.41e-06	194	263	9	459e836bcdb6742333684ac23d960efa5e99702f
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	KMT2E STAT4 SYNE2 SEPTIN1 SYNE1 ZNF507 RESF1 MACF1 CD96	2.74e-06	197	263	9	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	PARD6B ESYT2 KHDC1L TOX3 COL6A3 PYROXD2 KIAA1549 MUC16 HEATR5A	2.74e-06	197	263	9	a0a096e8e80763a92d5d7396eb678a4587771a3a
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDK4 TMEM132B STAB1 ADGRF5 PLTP HSPG2 SASH1 DSG2 NR2F2	2.74e-06	197	263	9	f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CTNNAL1 STAT4 SYNE2 KIF11 SYNE1 FANCI GZMK TOP2A CD96	2.85e-06	198	263	9	80b105a7c7d00ea3b5e586831fbb755bd84f9d1a
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CTNNAL1 STAT4 SYNE2 KIF11 SYNE1 FANCI GZMK TOP2A CD96	2.85e-06	198	263	9	c73e906d2d12d6eba0e606958be16e63a2292cd0
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYO7A PDK4 STAB1 C5AR1 PLTP SASH1 DAAM2 SIGLEC1 TNFAIP2	2.97e-06	199	263	9	b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	PDK4 STAB1 DST C5AR1 PLTP PLD4 SASH1 SIGLEC1 TNFAIP2	2.97e-06	199	263	9	96070b5ffcbab4952970f43b536969ddd2ca5d14
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TCAF1 TMEM132C FAT1 DST COL6A3 FAT4 NR2F2 PODN DAAM2	2.97e-06	199	263	9	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac\|GI_small-bowel / Manually curated celltypes from each tissue	PDK4 STAB1 DST C5AR1 PLTP PLD4 SASH1 SIGLEC1 TNFAIP2	2.97e-06	199	263	9	8990a3d69e24cb3aaba9d6def3d0be9ee973436d
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYO7A PDK4 STAB1 C5AR1 PLTP SASH1 DAAM2 SIGLEC1 TNFAIP2	2.97e-06	199	263	9	c0dcdda30485bb920d3706dcfb06f11b76b6ea37
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	AZU1 LIN7A FANCD2 KIF11 CHD7 RLF KANSL3 CIAO3 TOP2A	3.10e-06	200	263	9	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	mLN-Macrophage\|mLN / Region, Cell class and subclass	MYO7A PDK4 STAB1 C5AR1 PLTP SASH1 CDCP1 SIGLEC1 TNFAIP2	3.10e-06	200	263	9	68d709afd226241e002dae6d6820bccd1cfd87a1
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 DST SYNE2 ADGRF5 DYNC1H1 SASH1 RALGAPA2 RESF1 MACF1	3.10e-06	200	263	9	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 AHCYL1 ADGRV1 SLCO1C1 RAPGEF3 SASH1 SYNE1 GPAM MACF1	3.10e-06	200	263	9	d0812817ef99608994193787a62d39adeb2070ca
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDK4 TMEM132B STAB1 ADGRF5 PLTP HSPG2 SASH1 DSG2 NR2F2	3.10e-06	200	263	9	ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 DST SYNE2 ADGRF5 DYNC1H1 SASH1 RALGAPA2 RESF1 MACF1	3.10e-06	200	263	9	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	mLN-(6)_Macrophage\|mLN / shred on region, Cell_type, and subtype	MYO7A PDK4 STAB1 C5AR1 PLTP SASH1 CDCP1 SIGLEC1 TNFAIP2	3.10e-06	200	263	9	6dcba82a7d322102bae205543086e84c7655b3e0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 AHCYL1 ADGRV1 SLCO1C1 RAPGEF3 SASH1 SYNE1 GPAM MACF1	3.10e-06	200	263	9	cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACACA STAP1 RMC1 DNAH6 TTC38 PDIK1L LRRC1 MRNIP	3.15e-06	150	263	8	9cb3332924bd67c966873343c14445e30d3f384f
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NIBAN3 STAP1 DBNDD1 PTPRK KCNG1 BANK1 C12orf71 SDK2	3.31e-06	151	263	8	2314c004434aed9b7fa1ad01c61c43e5ed4a18ce
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-Gpr83_(Layer_5a)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	KLHL41 SCX STAT4 CDCP1 C4orf54 RGS13 GZMK	3.63e-06	108	263	7	5af010a1ee6535b144ccd16999c225508a4b3433
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLURP2 ARHGEF18 APOB CBY2 BPIFB2	4.15e-06	41	263	5	b1e70962de91a747ec718a3fad4247fd0cb7d9a8
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLURP2 ARHGEF18 APOB CBY2 BPIFB2	4.15e-06	41	263	5	16dbb13baa47c4db80ddd83ac36aad6c43b5461a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 STAP1 LIN7A TOX3 ADGRF5 SLC4A9 C4orf54 SLC26A7	4.63e-06	158	263	8	debebc8534a80e5500051f6fd352dc201585968d
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAP1 FOXRED2 DPEP3 OLFM1 PLTP SASH1 ARHGEF18 SIGLEC1	4.85e-06	159	263	8	323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 STAP1 LIN7A ADGRF5 SLC4A9 SDK2 DSG2 SLC26A7	5.08e-06	160	263	8	174a4ab27114efcc63be36929b80680be3c35c9b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 STAP1 ADGRF5 SLC4A9 MUC20 DSG2 TMEM31 SLC26A7	6.38e-06	165	263	8	a6c6de17fec678ad0cac3138dde3a14cc39ffd26
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ANKRD13B DBNDD1 KCNS2 UNC79 ADAMTS3 GRIK3 SLC45A1 EPHA8	6.97e-06	167	263	8	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ANKRD13B DBNDD1 KCNS2 UNC79 ADAMTS3 GRIK3 SLC45A1 EPHA8	6.97e-06	167	263	8	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTNNAL1 TMEM132B SDK2 PCDHA11 GRID2 PCDHA2 GRIK3 CHD7	6.97e-06	167	263	8	17c653b46507c8bb85da95836ae72a6015336142
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHS1 HMGCS2 TOX3 ADGRF5 SLC4A9 KLB DSG2 SLC26A7	6.97e-06	167	263	8	166b7b4ca0663cde6d88219ee0bcc1988d03dab8
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFM1 TLN2 C5AR1 SYNE1 RESF1 ETHE1 LY75 TOP2A	7.28e-06	168	263	8	faaba5ac01c2ebe380f56559374a121979a85a13
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTNNAL1 TMEM132B DST DBNDD1 PCDHA1 GRIK3 CHD7 COL18A1	7.28e-06	168	263	8	af82e07d1eec51fc6530155f37addbce6221885d
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NIBAN3 STAT4 ADAMTS3 DSG2 LAMA3 CDCP1 CDH15	7.71e-06	121	263	7	05c40fd39e6b6275f35aaad835f95a81fcbb0990
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNO SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75	8.28e-06	171	263	8	95e87987a2332fa646849fb0de785f1e0b8a07dd
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNO SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75	8.28e-06	171	263	8	36657e277aad75c4f157c1726c48e09b5836cf37
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TOX3 FAT4 SDK2 MXRA5 GRID2 CHD7 NR2F2 NR2E1	9.41e-06	174	263	8	fdadac1eaab2c4a67e4832f0901df22e893add6a
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CCNO PLEKHS1 NECTIN4 MUC20 KIF26B PCLO MUC16 CDCP1	9.41e-06	174	263	8	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75 TOP2A	1.11e-05	178	263	8	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75 TOP2A	1.11e-05	178	263	8	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DCHS2 DST C3 ADAMTS3 KIF26B SYNE1 LAMA3 NR2F2	1.16e-05	179	263	8	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A SYT9 PARD6B HSPG2 DPP6 LAMA3 HEATR5A LRRC1	1.25e-05	181	263	8	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75 TOP2A	1.30e-05	182	263	8	c075756cd4bb484ede1be2bcdb9eac60eab0573a
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE2 C3 C5AR1 KIF11 SYNE1 ETHE1 LY75 TOP2A	1.30e-05	182	263	8	9025178ede571e3808d4657ad4892152f336c9b4
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 SLC7A13 FTCD ADGRV1 DNAJC22 HNF4A UGT2A1 TRPV1	1.36e-05	183	263	8	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA HMGCS2 ADGRV1 C8orf34 FAT1 PTPRK TOX3 NECTIN4	1.41e-05	184	263	8	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	HMGCS2 FTCD HNF4A PTPRK TOX3 KLB GPAM COL18A1	1.47e-05	185	263	8	1d874608aa2062024323512f68889219471b2f00
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	CCNO PLEKHS1 PARD6B FAT1 PTPRK TOX3 MUC16 CATSPERB	1.53e-05	186	263	8	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ADGRV1 STAB1 PCLO LAMA3 MUC16 DAAM2 TNFAIP2 HDAC10	1.53e-05	186	263	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	DBNDD1 CAMTA1 UNC79 SYT13 KIF26B CAMSAP3 OGDH SLC45A1	1.53e-05	186	263	8	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	LPS_only-Myeloid-Dendritic_cells-pDC\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF280B NIBAN3 PLD4 TRPV1 SIGLEC1 CDH15 MTMR9	1.58e-05	135	263	7	0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO9A SYT9 ADGRV1 SYNE2 C3 DPP6 SDK2 LAMA3	1.59e-05	187	263	8	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	TMEM132C DST TLN2 COL6A3 FAT4 FAT3 PODN DAAM2	1.59e-05	187	263	8	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDHA9 HMGCS2 TMEM132C C3 C4B HSPG2 COL6A3 PODN	1.65e-05	188	263	8	b382d18fb09fb2869f3c151efa71540a7f5ed229
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	PDK4 STAB1 DST C5AR1 PLTP SASH1 SIGLEC1 TNFAIP2	1.65e-05	188	263	8	e83de94a9b47a6a90e98face887eae031a322af6
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDK4 HEPACAM KAT2B SLCO1C1 RAPGEF3 DOCK1 CHD7 DAAM2	1.65e-05	188	263	8	505b6b4277d7dea87aee27191d0acca67928b8e6
ToppCell	Healthy-B_naive\|World / disease group, cell group and cell class	NIBAN3 SCX STAP1 DBNDD1 PTPRK KCNG1 RAPGEF3 BANK1	1.71e-05	189	263	8	1e533a43f739ff295740cf2b25479756dfb8e595
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LIN7A TMEM132C FAT1 COL6A3 SYNE1 GRID2 NR2F2 DAAM2	1.71e-05	189	263	8	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	STAT4 SYNE2 TTC38 DMTF1 SYNE1 RESF1 MACF1 CD96	1.78e-05	190	263	8	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	Severe-Lymphoid-T-NK\|Severe / Condition, Lineage, Cell class and cell subclass	STAT4 SYNE2 SEPTIN1 KIF11 FANCI GZMK TOP2A CD96	1.78e-05	190	263	8	60642de433f84fa2cecd796c3a1a4aab9219d3db
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 MYO7A STAB1 C12orf71 SASH1 NR2F2 COL18A1 LRRC1	1.78e-05	190	263	8	26e2237f65cb43723c5da853831b40df2982d6e4
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HMGCS2 STAP1 TOX3 ADGRF5 SLC4A9 MUC20 DSG2 SLC26A7	1.78e-05	190	263	8	223587b5df037794a2cee234babf87d12bf48ac8
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 MYO7A STAB1 C12orf71 SASH1 NR2F2 COL18A1 LRRC1	1.78e-05	190	263	8	a1514d2186eb4fe569971ab22dc0c17d353fb94a
ToppCell	facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTNNAL1 MYO7A STAB1 C12orf71 SASH1 NR2F2 COL18A1 LRRC1	1.78e-05	190	263	8	0bb954a94317cfc742b9b6221bb80f8baa6d3ff1
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDK4 HEPACAM SLCO1C1 RAPGEF3 C3 DOCK1 CHD7 DAAM2	1.85e-05	191	263	8	a90c8ab2077e52bbc998457c85a1b9867f9c8c93
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF280B HEPACAM SYNE2 TTC38 SYNE1 NOL4L GZMK CD96	1.92e-05	192	263	8	97c312c82ec025c13052f8d424b11c0034c8ea54
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TCAF1 TMEM132C FAT1 TOX3 COL6A3 FAT4 FAT3 NR2F2	1.92e-05	192	263	8	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	PND28-Mesenchymal-Mesenchymal_structural\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM132C C3 C4B COL6A3 NR2F2 GYG1 PODN MACF1	1.99e-05	193	263	8	ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM132C C3 C4B COL6A3 NR2F2 GYG1 PODN MACF1	1.99e-05	193	263	8	30481fb01c7acf85beae10213f038da86bed6777
ToppCell	severe_influenza-B_naive\|severe_influenza / disease group, cell group and cell class (v2)	NIBAN3 STAP1 DBNDD1 PTPRK BANK1 PLD4 SDK2 CHD7	2.07e-05	194	263	8	7c1e9ce5de3bb1657a67010de673c8bb60129cb6
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	9.91e-11	29	254	8	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	8.78e-07	87	254	8	EFO_0004340, EFO_0004765
Disease	neutrophil count, basophil count	PCDHA9 HNF4A NUP160 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 CHD7	4.30e-06	224	254	11	EFO_0004833, EFO_0005090
Disease	neuroticism measurement, cognitive function measurement	PCDHA9 NUP210L BIRC6 STAB1 PTPRK RMC1 DSCAM PCLO ZNF507 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1 GRIK3	9.56e-06	566	254	17	EFO_0007660, EFO_0008354
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	HNF4A BANK1 PLTP GPAM APOB MACF1	2.47e-05	67	254	6	EFO_0008595, EFO_0020946
Disease	1-stearoylglycerol 1-monostearin measurement	SYNE2 KIAA1549	7.38e-05	2	254	2	EFO_0021111
Disease	post-traumatic stress disorder symptom measurement	SYNE1 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	7.77e-05	82	254	6	EFO_0008535
Disease	systemic lupus erythematosus (is_implicated_in)	STAT4 C3 C4A C4B BANK1	1.97e-04	62	254	5	DOID:9074 (is_implicated_in)
Disease	Hennekam syndrome (is_implicated_in)	FAT4 ADAMTS3	2.20e-04	3	254	2	DOID:0060366 (is_implicated_in)
Disease	Hennekam lymphangiectasia-lymphedema syndrome	FAT4 ADAMTS3	2.20e-04	3	254	2	C0340834
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	HNF4A SYNE2 BANK1 GPAM APOB MACF1	2.73e-04	103	254	6	EFO_0008595, EFO_0020944
Disease	cortical thickness	ANKRD13B GALK2 NUP210L ADGRV1 ELAC2 STAB1 PI4KA TOX3 DLEC1 CAMTA1 BANK1 AGAP3 HSPG2 ADAMTS3 FAT3 CHD7 NR2F2 COL18A1 NOL4L CBY2 FMN2 MACF1	2.75e-04	1113	254	22	EFO_0004840
Disease	hair colour measurement	ADGRV1 LYST SPATA33 DBNDD1 RBM27 SYNE2 TOX3 SASH1 MTERF1 RANBP6 FMN2 CATSPERB BPIFB2 SLC45A1 CDH15	3.16e-04	615	254	15	EFO_0007822
Disease	Lupus Erythematosus, Systemic	STAT4 C4A C4B BANK1 PHRF1	3.72e-04	71	254	5	C0024141
Disease	post-traumatic stress disorder	KAT2B KHDC1L DPP6 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	3.85e-04	202	254	8	EFO_0001358
Disease	phospholipids in large HDL measurement	HNF4A BANK1 PLTP GPAM APOB	4.24e-04	73	254	5	EFO_0022190
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	4.38e-04	4	254	2	cv:CN293514
Disease	X-22162 measurement	TTC38 PYROXD2	4.38e-04	4	254	2	EFO_0800839
Disease	Usher Syndrome	MYO7A PLD4	4.38e-04	4	254	2	C0271097
Disease	free cholesterol to total lipids in large LDL percentage	BANK1 PLTP GPAM APOB MACF1	4.51e-04	74	254	5	EFO_0022280
Disease	vital capacity	PCDHA9 MFSD6 KMT2E C8orf34 DST RMC1 AGAP3 HSPG2 COL6A3 ADAMTS3 SYNE1 PCLO PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 APOB PCDHA1 CHD7 PDIK1L OTOG	4.67e-04	1236	254	23	EFO_0004312
Disease	systemic lupus erythematosus (implicated_via_orthology)	C4A C4B PLD4 BECN1	5.08e-04	43	254	4	DOID:9074 (implicated_via_orthology)
Disease	white matter microstructure measurement	ANKRD13B SPATA33 BANK1 SLC4A9 SDK2 SASH1 APOB PCDHA1 XRCC4 CARF CATSPERB	6.13e-04	390	254	11	EFO_0005674
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	HNF4A SYNE2 BANK1 GPAM APOB MACF1	6.46e-04	121	254	6	EFO_0008595, EFO_0020943
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	7.26e-04	5	254	2	C1450051
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE2 SYNE1	7.26e-04	5	254	2	C0410190
Disease	DiGeorge syndrome (is_implicated_in)	DVL1P1 DVL1	7.26e-04	5	254	2	DOID:11198 (is_implicated_in)
Disease	Hypoplastic Left Heart Syndrome	PCDHA9 PCDHA13	7.26e-04	5	254	2	C0152101
Disease	Abnormality of refraction	PCDHA9 BIRC6 DPEP3 DLEC1 DSCAM FAT3 PCLO PHRF1 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 PCDHA1	7.98e-04	673	254	15	HP_0000539
Disease	thalamus volume	ADGRV1 CAMTA1 DPP6 FAT3 MACF1	8.51e-04	85	254	5	EFO_0006935
Disease	cholesteryl esters to total lipids in IDL percentage	BANK1 GPAM APOB MACF1	9.05e-04	50	254	4	EFO_0022247
Disease	Immunologic Deficiency Syndromes	C3 C4A CHD7	9.83e-04	23	254	3	C0021051
Disease	pulse pressure measurement	PCDHA9 MRPS27 AKR1A1 UGT2A1 TLN2 DLEC1 NUP160 KLB COL6A3 MXRA5 DSCAM MTERF1 FAT3 PCDHA13 PCDHA11 PCDHA8 PCDHA6 PCDHA4 PCDHA2 HEATR5A PCDHA1 SLC26A7 TET1 LRRC1	1.02e-03	1392	254	24	EFO_0005763
Disease	Emery-Dreifuss muscular dystrophy	SYNE2 SYNE1	1.08e-03	6	254	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE2 SYNE1	1.08e-03	6	254	2	C0410189
Disease	congenital muscular dystrophy (implicated_via_orthology)	DYNC1H1 COL6A3	1.08e-03	6	254	2	DOID:0050557 (implicated_via_orthology)
Disease	Behcet Syndrome	STAT4 C4A APOB	1.12e-03	24	254	3	C0004943
Disease	nephrotic syndrome (biomarker_via_orthology)	GPAM APOB SERPINC1	1.12e-03	24	254	3	DOID:1184 (biomarker_via_orthology)
Disease	Squamous cell carcinoma of esophagus	FAT1 DLEC1 FAT4 FAT3 TYMP	1.40e-03	95	254	5	C0279626
Disease	N6-methyllysine measurement	PYROXD2 GPAM	1.51e-03	7	254	2	EFO_0800061
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE2 SYNE1	1.51e-03	7	254	2	C0751337
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	HNF4A SYNE2 PLTP APOB OGDH MACF1	1.59e-03	144	254	6	EFO_0004611, EFO_0020943
Disease	neurodegenerative disease (implicated_via_orthology)	DVL1P1 DYNC1H1 FAT4 DVL1 GRIK3 OGDH	1.65e-03	145	254	6	DOID:1289 (implicated_via_orthology)
Disease	cholesterol to total lipids in IDL percentage	BANK1 GPAM APOB MACF1	1.79e-03	60	254	4	EFO_0022233
Disease	free cholesterol to total lipids in medium HDL percentage	HNF4A PLTP GPAM APOB	1.79e-03	60	254	4	EFO_0022282
Disease	free cholesterol in HDL measurement	HNF4A PLTP GPAM APOB	1.90e-03	61	254	4	EFO_0022264
Disease	phospholipids in HDL measurement	HNF4A PLTP GPAM APOB	1.90e-03	61	254	4	EFO_0022293
Disease	hippocampus volume change measurement, age at assessment	TMEM132C MOCS3 KCNG1	1.95e-03	29	254	3	EFO_0008007, EFO_0021492
Disease	common bile duct neoplasm (is_marker_for)	APOB TYMP	2.00e-03	8	254	2	DOID:4608 (is_marker_for)
Disease	ribose-5-phosphate measurement, ribulose-5-phosphate measurement	TMEM132C GRID2	2.00e-03	8	254	2	EFO_0010529, EFO_0010530
Disease	neutrophil count	PCDHA9 NUP210L KMT2E HNF4A OLFM1 TLN2 ADGRF5 RMC1 ZNF282 NUP160 C12orf71 DSCAM PCDHA13 PCDHA11 PCDHA8 GPAM PCDHA6 PCDHA4 PCDHA2 PCDHA1 CHD7 MRNIP LY75	2.04e-03	1382	254	23	EFO_0004833
Disease	total lipids in HDL measurement	HNF4A PLTP GPAM APOB	2.15e-03	63	254	4	EFO_0022307
Disease	lipoprotein measurement	HNF4A PLTP DOCK1 GPAM APOB	2.18e-03	105	254	5	EFO_0004732
Disease	unipolar depression, bipolar disorder	SYNE2 DMTF1 FAT4 SYNE1 PCLO GRIK3	2.38e-03	156	254	6	EFO_0003761, MONDO_0004985
Disease	total lipids in very large HDL measurement	BANK1 PLTP GPAM APOB	2.54e-03	66	254	4	EFO_0022312
Disease	phospholipids in very large HDL measurement	BANK1 PLTP GPAM APOB	2.54e-03	66	254	4	EFO_0022298
Disease	RNA-binding protein 24 measurement	C3 PIKFYVE	2.55e-03	9	254	2	EFO_0802030
Disease	X-21467 measurement	SLCO1C1 MTERF1	2.55e-03	9	254	2	EFO_0020007
Disease	obesity (implicated_via_orthology)	DCHS2 HNF4A STAT4 C3 C5AR1 FAT4 SDK2	2.71e-03	215	254	7	DOID:9970 (implicated_via_orthology)
Disease	Benign Neoplasm	PLEKHS1 BIRC6 TRPV1 ATF2	2.84e-03	68	254	4	C0086692
Disease	Neoplasms	PLEKHS1 BIRC6 TRPV1 ATF2	2.84e-03	68	254	4	C0027651
Disease	triglycerides to phosphoglycerides ratio	BANK1 PLTP GPAM APOB	2.84e-03	68	254	4	EFO_0022327
Disease	Complement deficiency disease	C3 C4A C4B	2.84e-03	33	254	3	C0272242
Disease	cholesterol in very large HDL measurement	BANK1 PLTP GPAM APOB	2.99e-03	69	254	4	EFO_0022229
Disease	Alzheimer disease, age at onset	DCHS2 AHCYL1 TMEM132C FAT1 DST PUM3 BANK1 HSPG2 COL18A1	3.06e-03	343	254	9	EFO_0004847, MONDO_0004975
Disease	DNA-directed RNA polymerases I and III subunit RPAC1 measurement	C3 PIKFYVE	3.17e-03	10	254	2	EFO_0801535
Disease	OCIA domain-containing protein 1 measurement	C3 PIKFYVE	3.17e-03	10	254	2	EFO_0008252
Disease	diabetes mellitus biomarker	KIF11 GRID2	3.17e-03	10	254	2	EFO_0006842
Disease	thrombosis (implicated_via_orthology)	C5AR1 SERPINC1	3.17e-03	10	254	2	DOID:0060903 (implicated_via_orthology)
Disease	cancer antigen 125 measurement	MUC16 CIAO3	3.17e-03	10	254	2	EFO_0010603
Disease	Fanconi anemia (is_implicated_in)	FANCD2 FANCI	3.17e-03	10	254	2	DOID:13636 (is_implicated_in)
Disease	childhood trauma measurement, alcohol consumption measurement	C8orf34 PCDHGA11 PCDHGA6 PCDHGA8	3.32e-03	71	254	4	EFO_0007878, EFO_0007979
Disease	high density lipoprotein particle size measurement	AHCYL1 HNF4A BANK1 PLTP GPAM APOB	3.64e-03	170	254	6	EFO_0008592
Disease	total lipids in large HDL	BANK1 PLTP GPAM APOB	3.85e-03	74	254	4	EFO_0022189
Disease	cytochrome p450 3a4 measurement	APOB PIKFYVE	3.86e-03	11	254	2	EFO_0020303
Disease	diffuse scleroderma (is_implicated_in)	STAT4 BANK1	3.86e-03	11	254	2	DOID:1580 (is_implicated_in)
Disease	Sodium measurement	DVL1 PRDM12	3.86e-03	11	254	2	C0337443
Disease	Adverse Event by CTCAE Category	DVL1 PRDM12	3.86e-03	11	254	2	C1879645
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	3.86e-03	11	254	2	EFO_0021493
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HNF4A SYNE2 BANK1 PLTP GPAM APOB MACF1 MTMR9	3.89e-03	291	254	8	EFO_0008317, EFO_0020946
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE2 SYNE1	4.60e-03	12	254	2	DOID:11726 (implicated_via_orthology)
Disease	amyloid plaque accumulation rate	MOCS3 KCNG1	4.60e-03	12	254	2	EFO_0007646
Disease	free cholesterol in large HDL measurement	BANK1 PLTP GPAM APOB	4.86e-03	79	254	4	EFO_0022157
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	HNF4A SYNE2 GPAM APOB MACF1	4.93e-03	127	254	5	EFO_0008595, EFO_0020947
Disease	cholesterol in large HDL measurement	BANK1 PLTP GPAM APOB	5.08e-03	80	254	4	EFO_0021900
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	AHCYL1 HNF4A BANK1 PLTP GPAM APOB MACF1 CDH15	5.34e-03	307	254	8	EFO_0004612, EFO_0020946
Disease	hyperglycemia (is_marker_for)	ITGAV HSPG2	5.41e-03	13	254	2	DOID:4195 (is_marker_for)
Disease	neuroimaging measurement	DCHS2 CTNNAL1 UBAP2 ELAC2 TOX3 TLN2 CAMTA1 BANK1 SLC4A9 AGAP3 ADAMTS3 KIF26B FAT3 CHD7 XRCC4 NR2F2 COL18A1 MACF1	5.45e-03	1069	254	18	EFO_0004346
Disease	liver cirrhosis (is_marker_for)	HNF4A IL18BP THPO BECN1	5.55e-03	82	254	4	DOID:5082 (is_marker_for)
Disease	severe acute respiratory syndrome, COVID-19	MYO7A LYST LIN7A TMEM132C TOX3 CAMTA1 COL6A3 MXRA5 ARHGEF18 PCDHA6	5.66e-03	447	254	10	EFO_0000694, MONDO_0100096
Disease	Fanconi anemia	FANCD2 FANCI	6.27e-03	14	254	2	cv:C0015625
Disease	thalamus volume change measurement	FAT1 KIF26B	6.27e-03	14	254	2	EFO_0021496
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	ADAMTS3 APOB	6.27e-03	14	254	2	EFO_0004611, EFO_0008589
Disease	5-methyluridine (ribothymidine) measurement	PCLO TYMP	6.27e-03	14	254	2	EFO_0020013
Disease	Malignant Head and Neck Neoplasm	FANCD2 FAT1 FANCI	6.44e-03	44	254	3	C0278996
Disease	ornithine measurement	MED23 DPP6 OGDH	6.44e-03	44	254	3	EFO_0009776
Disease	triglycerides to total lipids in chylomicrons and extremely large VLDL percentage	PLTP APOB	7.20e-03	15	254	2	EFO_0022328
Disease	Hypertriglyceridemia	PLTP APOB	7.20e-03	15	254	2	C0020557
Disease	sickle cell anemia (is_implicated_in)	C3 APOB	8.18e-03	16	254	2	DOID:10923 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEELPTATLTLTLRT	SYT13	231	Q7L8C5
SEAVTVLPASQLESR	ZNF280B	96	Q86YH2
ELSEASRNTIPLAVV	BANK1	186	Q8NDB2
TPSISQRELRIETIA	AGAP3	306	Q96P47
QRELRIETIAASSTP	AGAP3	311	Q96P47
IASDISLPIATQELR	ESYT2	756	A0FGR8
VDASVLVRQISLSPS	EP400	171	Q96L91
LELVEQVTRVESLSP	SLC4A9	151	Q96Q91
TQILVELRSSTFPES	CCDC186	116	Q7Z3E2
PTVLESELVQRIQTL	ARHGEF18	981	Q6ZSZ5
TLSVNSISTLEPVSR	CFAP410	46	O43822
LPTNVSEELVLSTTL	CAMTA1	456	Q9Y6Y1
LIQPVDTISISSLRQ	CAGE1	106	Q8TC20
PEDLIQTSSTEQLRT	BIRC6	2011	Q9NR09
QSSVQLLETIDEPLT	BIRC6	2451	Q9NR09
LSDVLDRVSDTPSIT	BIRC6	3866	Q9NR09
LVDIPRENITQSTDI	CATSPERB	111	Q9H7T0
LTVNTLDRFLTTTPV	CCNO	156	P22674
IIPQTISELQLSVSA	C4B	436	P0C0L5
PEILSRSQTQTLESL	ALS2	1336	Q96Q42
DAEATRTALTPEITL	ADGRG4	576	Q8IZF6
RTALTPEITLASTVA	ADGRG4	581	Q8IZF6
SVTLTPRTVDLTVIL	CDCP1	656	Q9H5V8
QSSLVPALTDFVRSV	CUTA	126	O60888
SLRPSDTLREVTVTV	GZMK	161	P49863
QITVTAELDRETLPI	FAT4	3461	Q6V0I7
GQRSTVLDVILTPET	ADGRV1	5571	Q8WXG9
ETVTFNSSLLRPRVI	C8orf34	256	Q49A92
VPDTESETRILLQGT	C3	971	P01024
ISPTQRAEVIRILST	ACACA	2326	Q13085
AIPTRTVAISDAAQL	EIF4EBP2	16	Q13542
IITSDSLAPRVDAIS	ACSM5	166	Q6NUN0
VPNVLLTSSDSSVII	ATF2	171	P15336
SVASVTVPIRLDTLS	C19orf84	51	I3L1E1
TISERVETQPLLRLT	ADCY7	656	P51828
TDVIPSEAINELTVL	SERPINC1	231	P01008
PSLLRNVLTEESVVR	C5AR1	316	P21730
SQVPVQTRSSILLAE	CAMSAP3	816	Q9P1Y5
SIIEPITEERASRTL	CHD7	2041	Q9P2D1
IQASDVIDTESVLPL	DMTF1	706	Q9Y222
LASVEQITIVSRPLS	ARIH2OS	196	Q8N7S6
SINSNITRVVLEPDS	RBM27	546	Q9P2N5
EPALTATATVLVSLV	PCDHA9	656	Q9Y5H5
NIDALEASIVISVSP	HSPG2	2701	P98160
RLPSLRTVSSSVIEQ	NR2F2	366	P24468
EVIITSLFSPVLENS	PCDHGA8	346	Q9Y5G5
PEITITSSINSILEN	PCDHGA11	346	Q9Y5H2
IISEIISSLPSIVND	PUM3	421	Q15397
LPRVVQTLLRTVEAS	NIBAN3	376	Q86XR2
EPALTATATVLVSLV	PCDHA2	656	Q9Y5H9
EPALTATATVLVSLV	PCDHA6	656	Q9UN73
VPNTESLESLTQIEL	PARD6B	311	Q9BYG5
LSSRTLPEIVASLTE	KIAA1549	261	Q9HCM3
TTVLSQSLEETISPR	KIAA1549	326	Q9HCM3
VSELPLRSLEETVSA	MRNIP	66	Q6NTE8
EIDILPTQLVNTSSV	PDK4	71	Q16654
SESSFTPLVVIELAQ	ANO10	11	Q9NW15
LSRLTAPVVTTQLDT	ANKRD13B	231	Q86YJ7
VTERVLAPASTLQSS	DSG2	1046	Q14126
AQPEAISTIAQSLRT	DAAM2	196	Q86T65
AALLAATVPEQRTVT	DEPDC5	1341	O75140
VITAVTLSPSELDRD	FAT1	256	Q14517
LEQVLNRVVTRASSP	FANCI	441	Q9NVI1
STPAFLETRRIQTEL	MUC16	7811	Q8WXI7
IQIEPTSSLTSGLRE	MUC16	8406	Q8WXI7
DISTEVITRLSTSPI	MUC16	9056	Q8WXI7
SPDIITEVITRLSSS	MUC16	9931	Q8WXI7
PALTATATVLVSLVE	PCDHA11	656	Q9Y5I1
IRSVDANVLTPIRSL	PODN	321	Q7Z5L7
QSIEAPLTATDTAIL	DNAJC11	166	Q9NVH1
SDPRVAQVTTLILSV	OR11A1	191	Q9GZK7
PLSTETIISLNVADT	PCDHGA6	431	Q9Y5G7
EPALTATATVLVSLV	PCDHA8	656	Q9Y5H6
EQTSIRSPQTRILLV	KLHL34	271	Q8N239
AATRPSSVLIEQLAV	MDN1	651	Q9NU22
EALPDILTSIIRTSN	LONP2	181	Q86WA8
TLTVVQPLTLDRDVA	LIN7A	16	O14910
VQRLSLSPEVLDLTS	LAMA3	2901	Q16787
PRADLQQIIVSLTES	KAT2B	121	Q92831
ALVTVSRNPLEETSA	MUC20	521	Q8N307
LQVTSLAQIILEPRS	MTMR9	341	Q96QG7
SSVPTLRSELNVVLQ	DST	1141	Q03001
LLVRATPVSQTTTAA	IL18BP	26	O95998
SIIATISPASLNLEE	KIF11	331	P52732
SRPVSIISSISEDLE	KIF26B	1226	Q2KJY2
RVTIQELTAPLLTTA	BECN1	36	Q14457
VLPITTREANNSLIS	CARF	46	Q8N187
ILVSATIPTSIEQLA	DDX59	381	Q5T1V6
LQAEVLSRQITSPVS	HNF4A	156	P41235
ILQLTRAVQETSLTP	HMGCS2	11	P54868
TFIPEQIQTLSRTLS	GRID2	931	O43424
VSLQQSPLVLSSVVE	PCLO	4631	Q9Y6V0
TRSTLVAIRPLDVST	PCSK4	516	Q6UW60
TVLSALSREPTVDIS	PDCD6IP	166	Q8WUM4
LNSLLDTVPVRSSVD	PLTP	196	P55058
LAEVRVSASTLPTVL	OR51J1	71	Q9H342
NIVVSRLDPVSLQTL	OLFM1	376	Q99784
TVPTESLARAETLVL	COL18A1	131	P39060
ISLEELRTQILSPNT	GALK2	306	Q01415
VATQTRDIDPIITRL	INTS2	1136	Q9H0H0
VVNLVVESTPTLANL	KCNS2	276	Q9ULS6
DRIVSVISSPSLTSE	MED23	1166	Q9ULK4
EVVSQTPLLRSRALV	PHRF1	1386	Q9P1Y6
VTPAELSELRSTIIN	PI4KA	856	P42356
TEFPQERSSISLVSL	KLHL41	526	O60662
TALAEIITETEVPAL	KMT2E	706	Q8IZD2
GLSTESILIPRQSET	LCN1	156	P31025
TLPSVLSQIEQDFIT	LY75	986	O60449
VATRVLELSIPASAE	LAMB2	1536	P55268
LRSPENVIETISSLL	GCN1	271	Q92616
DRVLPQLISTITASV	GCN1	736	Q92616
AVNLSVSTLPSLREE	KCNG1	241	Q9UIX4
SLVLPAEVIIAQSSI	PRDM12	81	Q9H4Q4
VLIVVTITASPSLRS	OR4C13	41	Q8NGP0
ADLVTSVLSSPIRRE	PPP4R3B	146	Q5MIZ7
ELPITQLTSSIVRRV	FOXRED2	426	Q8IWF2
LLETRLNVSDTVTLP	MFSD6	201	Q6ZSS7
TAQLSPTEISAVRQL	NOL4L	396	Q96MY1
SILIDESEPTTNIQI	NSFL1C	286	Q9UNZ2
TDILTAPRSEAVTVL	RALGAPA2	1091	Q2PPJ7
LETTAVLPVQIQLTT	LRRC70	476	Q7Z2Q7
RLTRIPAEVSQATEL	LRRC1	346	Q9BTT6
SSVPTLRSELNLLVE	MACF1	1126	Q9UPN3
VTLDPVQLESSLLRS	MACF1	4936	Q9UPN3
TVSRLDRESIPTVIL	DCHS2	1571	Q6V1P9
EDAPLSTVIALITVS	PCDHA1	361	Q9Y5I3
EPALTATATVLVSLV	PCDHA1	656	Q9Y5I3
EDTQPSAIIALISVS	PCDHA13	361	Q9Y5I0
PTLARTSTDLQVLAA	PLD4	181	Q96BZ4
EPALTATATVLVSLV	PCDHA4	656	Q9UN74
VTDRNITLSLVANPS	OGDH	361	Q02218
DTRSESLEIPISVVL	CBY2	36	Q8NA61
DPRTAVQLRSLSTVL	PIKFYVE	121	Q9Y2I7
SNTPLSTRLVSVQED	PIKFYVE	281	Q9Y2I7
EAVTSLLPQLIEVSS	APOB	361	P04114
IVLIIPQENDTRSSL	ADAMTS3	806	O15072
TSTLINTILEVQPRS	DNAH6	3831	Q9C0G6
RTAVALTTPDITLVL	HDAC10	411	Q969S8
TRESPSIQLASLEVV	HEATR5A	1616	Q86XA9
TTRRLVVLATPQVSD	GYG1	31	P46976
RIISIEIETPTQISL	DCLRE1C	81	Q96SD1
LQQSEAVILSETISP	DOCK1	1721	Q14185
SVEQTLLPLVSQITT	CTNNAL1	36	Q9UBT7
ETSLIIPSLERLVNA	CEP290	671	O15078
TERRQPLSSVSSLEV	DBNDD1	56	Q9H9R9
SQIVSVLDALIRSPE	EPHA8	886	P29322
LPIEDITNSTLVTTN	ITGAV	966	P06756
TELQTITNDPRLVFT	COL6A3	1581	P12111
SIVRSLDNSPLVIRA	FAT3	1786	Q8TDW7
REPLTAQQLETTTER	CC2D1A	791	Q6P1N0
PSLVRETSRITVLEA	ATAD3C	106	Q5T2N8
LLASISRIAQDPSSV	ATG9B	796	Q674R7
TIALTASEVINPLIE	EID2	211	Q8N6I1
SDIIDILRTPENVTQ	LYST	2661	Q99698
TVSTVEEERTLNPRL	ETHE1	201	O95571
TALQAALTVRPEIVS	MANEAL	386	Q5VSG8
RPVALTVTFALDNTT	ITGA10	751	O75578
VSSQLRVLTLSEDSP	DYNC1H1	131	Q14204
TIVRTIPVATTLSSL	KANSL3	801	Q9P2N6
VRSQPLTNDDLVTSV	KHDC1L	106	Q5JSQ8
QDITRLSSPTRLAVI	KLB	851	Q86Z14
SRPQVLVASTTVLEL	HEPACAM	146	Q14CZ8
LREIVSQTGPISLTV	DVL1	321	O14640
SDTLIRRVLEVSQAP	DPEP3	271	Q9H4B8
VTSVILLTPAEDNSL	DPP6	111	P42658
LREIVSQTGPISLTV	DVL1P1	321	P54792
LTNRSLIVTTVLEEP	GRIK3	431	Q13003
LDREANLTSSVTILP	AZU1	121	P20160
RVVTLLEPLNVRSES	C4orf54	746	D6RIA3
SLIVSPRRISVQLDS	FMN2	786	Q9NZ56
LRAVVAVPELQLSTS	DLEC1	1626	Q9Y238
AILPISVAASITAQR	DNAJC22	151	Q8N4W6
PSSRIAITLENTLVI	SDK2	156	Q58EX2
PVATLSTVERRAINL	SDK2	596	Q58EX2
ALQRLVELTTSRVTP	SBK3	21	P0C264
LSVTTVLTLVSIPER	SLC45A1	311	Q9Y2W3
QPRTATGTLSIEILE	CDH15	461	P55291
TTQEAERILLRTQTP	PPHLN1	416	Q8NEY8
SLQLLSPEERVSVTD	MOCS3	326	O95396
LELTPTTSLSTRVNR	TACR2	336	P21452
IIPQTISELQLSVSA	C4A	436	P0C0L4
RAVSVPLTLAETVAS	FTCD	446	O95954
IENTSLTVPILDVLS	FANCD2	236	Q9BXW9
AVSTTPERQTLVSLA	NR2E1	146	Q9Y466
AESTQPIRLSSIILA	NUP210L	96	Q5VU65
LNETATTITVLLRPA	PTPRK	606	Q15262
PREINIDSSTRETII	RGS13	96	O14921
VSPLATRSLEIVLST	OTOG	1721	Q6ZRI0
ALQDVPLSSVVRSII	MRPL11	131	Q9Y3B7
VISTLQILPTVREDS	DSCAM	846	O60469
IIASPLVSTDSVLVA	GPRASP1	116	Q5JY77
PVSSLTISRLIDNIS	MRPS27	66	Q92552
RDPDISVSLLTLVVT	SYT9	46	Q86SS6
LQVELTSPVFLTDIT	RGSL1	561	A5PLK6
IALVELSVPVTLSSR	TPSG1	126	Q9NRR2
LDSQSIIRPLTVEEV	SLC9C1	851	Q4G0N8
TDRPLLSTLEESVVR	SMG5	751	Q9UPR3
APESRVVAQVLTLLD	SPATA5L1	316	Q9BVQ7
LSRQLEVVESSIPSV	SYNE1	6701	Q8NF91
TVQVLSPLSDSILAE	TMEM132B	631	Q14DG7
TIQVLSPLSDSILAE	TMEM132C	641	Q8N3T6
VNLSELESIVTERPQ	SYNE2	4361	Q8WXH0
ILISTLPSVSLVEET	SYNE2	4856	Q8WXH0
TDNIILTVPTANLRT	TCAF1	666	Q9Y4C2
NTEIDVTSLRTPELT	AHCYL1	401	O43865
TELQIAVVSPLVLSE	RESF1	756	Q9HCM1
LLSVVVDTLSTNVIP	GPAM	331	Q9HCL2
LISQTRLDTSDLEPT	PDIK1L	171	Q8N165
QLRAIIEADPLTTTR	SETMAR	416	Q53H47
PERVASLDTVVSVLR	IQANK1	261	A8MXQ7
NITSLVRLSTTVPNT	PIAS1	251	O75925
STLQTVRIERSPLLD	NOPCHAP1	56	Q8N5I9
PELVIQLATSAITEA	NUP160	976	Q12769
LALEVIVTLSETATP	RANBP6	286	O60518
DAAIISTLVSSVLPV	NCKIPSD	471	Q9NZQ3
STLVSSVLPVELARD	NCKIPSD	476	Q9NZQ3
ATRVLSNTEDLPLVT	SLURP2	51	P0DP57
VVAIEALTQLSEAPS	TET1	891	Q8NFU7
TLPVELLADTRVTQS	BPIFB2	111	Q8N4F0
ILDLLSTVPTQVNSE	ADGRF5	776	Q8IZF2
SRQIDDILSVASVRP	AKR1A1	166	P14550
DILSVASVRPAVLQV	AKR1A1	171	P14550
LVVVSVSPQSRASLA	CIAO3	111	Q9H6Q4
QRTSAPEISSILSEQ	C12orf71	181	A8MTZ7
VPEASARLTQTLAIE	SEPTIN1	61	Q8WYJ6
PQIIITRASNETLVS	SPATA33	86	Q96N06
TPRSVLLELDNIIAS	PLEKHS1	211	Q5SXH7
TTSSDRTINLLEVLP	TMEM31	61	Q5JXX7
VLTLQLPVTASVREV	RAPGEF3	571	O95398
VLSETTLAQPQSLER	UBXN6	241	Q9BZV1
LQLPSTTIENISVSV	UBAP2	481	Q5T6F2
TLENIIATVDTRLPE	TNFAIP2	491	Q03169
LDLVDRQSITLISSP	ZSWIM7	46	Q19AV6
IRNVSATLVNISPDT	ELAC2	496	Q9BQ52
SVTLVDVSALRPNTT	CD96	416	P40200
LIVAETTTVPSLENL	RLF	1846	Q13129
TTTVPSLENLRVVLD	RLF	1851	Q13129
NTTIPLLLEIARQTD	TRPV1	171	Q8NER1
FLERISQLDTRSPVT	PYROXD2	361	Q8N2H3
PESAVILLSTTVLEN	RMC1	161	Q96DM3
AVLRENLSPTTIETA	STAT4	726	Q14765
TITQIERRFDIPSSL	SLCO1C1	66	Q9NYB5
ILTVTELSVPQNVSL	STAP1	116	Q9ULZ2
ITLDPQTASRSLVLS	TRIM15	296	Q9C019
SIISSLDVTDIAPSR	XRCC4	256	Q13426
AEILVTLSQVIISPA	UNQ5815/PRO19632	46	Q6UWF5
SISQIIENPRVLDSS	MTERF1	341	Q99551
SPTSLQLRSQIEESL	SASH1	101	O94885
VTALVPSEAAVRQLS	STAB1	1021	Q9NY15
VSSVAAQRLVLDTLP	RGS14	431	O43566
LTVLTPREILSSDAV	SLC7A13	261	Q8TCU3
LETVTLLPVARTDAA	SIGLEC1	756	Q9BZZ2
LDLPSITISRNLVEQ	TOX3	111	O15405
SPENRATQSILILVS	VN1R4	226	Q7Z5H5
ESRPRLSQLSVTDVT	TNXA	141	Q16473
PRQLLLQVESTTVAT	RIOX2	291	Q8IUF8
PEITVRSVLLSRSQQ	RWDD2B	116	P57060
VEAVESTLQTPLDIR	TRIM14	216	Q14142
LNSTTIEISELPVRT	TOP2A	916	P11388
EQEAILTAESIISPS	ZNF507	16	Q8TCN5
NVIVERLPSAEETLS	ZNF507	396	Q8TCN5
PQTTQELLTTLRDAS	TTC38	346	Q5R3I4
RIATAPLIEAVENLT	TLN2	1561	Q9Y4G6
TIAIIETSQPLALED	ZNF526	631	Q8TF50
TVSSRPSVEQLSSLI	TRAPPC8	1296	Q9Y2L5
ATVDSQVAIATELPL	WDCP	211	Q9H6R7
STEEVNTPLILISSA	PIGG	281	Q5H8A4
VNTAFTALRTLIPTE	SCX	91	Q7RTU7
LTSLISANAVERIVP	SLC26A7	106	Q8TE54
RSSPESRVTQSILVL	VN1R3	226	Q9BXE9
VVATQLPESTSLRLA	NAE1	126	Q13564
VDLLSALRTVINEPS	UGT2A1	421	P0DTE4
VSQLPRLESLDISNT	ZYG11A	201	Q6WRX3
EATLRTQSLSLAVIP	ZFYVE26	2136	Q68DK2
SLSTLSAIATPRIIE	THEGL	331	P0DJG4
PSVTIEQRRLAVDLS	TRRAP	1996	Q9Y4A5
ARDVTATVDSLPLIT	TYMP	201	P19971
ITDSPISAQDLLSRI	ZNF282	316	Q9UDV7
LTVQVLPSVDIDSIS	KIAA0586	796	Q9BVV6
VLSLSTAPLVQVSVE	UNC79	1676	Q9P2D8
AVPSRTSLVLTLNEL	THPO	181	P40225
ETTVAILLSETRPQN	MXRA5	1466	Q9NR99
TVSTPLSREQALDVR	MYO7A	381	Q13402
SRLTSEDRTVPLVVE	MYO9A	2066	B2RTY4
VREIETQTELLSPGS	NECTIN4	451	Q96NY8